These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33909604)

  • 41. The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity.
    Luo M; Zhang Z; Peng Y; Wang S; Peng D
    Cardiovasc Diabetol; 2018 Nov; 17(1):142. PubMed ID: 30409151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CRISPR/Cas9-mediated
    Izumi R; Kusakabe T; Noguchi M; Iwakura H; Tanaka T; Miyazawa T; Aotani D; Hosoda K; Kangawa K; Nakao K
    J Lipid Res; 2018 Sep; 59(9):1575-1585. PubMed ID: 30042156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study.
    Morinaga J; Zhao J; Endo M; Kadomatsu T; Miyata K; Sugizaki T; Okadome Y; Tian Z; Horiguchi H; Miyashita K; Maruyama N; Mukoyama M; Oike Y
    PLoS One; 2018; 13(3):e0193731. PubMed ID: 29538435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity.
    Barkas F; Elisaf M; Liberopoulos E; Liamis G; Ntzani EE; Rizos EC
    J Cardiol; 2019 Sep; 74(3):290-295. PubMed ID: 30910387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.
    Musunuru K; Kathiresan S
    Circ Res; 2016 Feb; 118(4):579-85. PubMed ID: 26892959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HDL
    Chaudhary R; Kinderytė M; Chaudhary R; Sukhi A; Bliden K; Tantry U; Gurbel P
    Cardiovasc Revasc Med; 2019 Nov; 20(11):1001-1006. PubMed ID: 30626544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A null mutation in ANGPTL8 does not associate with either plasma glucose or type 2 diabetes in humans.
    Clapham KR; Chu AY; Wessel J; Natarajan P; Flannick J; Rivas MA; Sartori S; Mehran R; Baber U; Fuster V; Scott RA; Rader DJ; Boehnke M; McCarthy MI; Altshuler DM; Kathiresan S; Peloso GM
    BMC Endocr Disord; 2016 Jan; 16():7. PubMed ID: 26822414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL.
    Rallidis LS; Kiouri E; Katsimardos A; Kotakos C
    Atherosclerosis; 2018 Aug; 275():262-264. PubMed ID: 29980053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
    Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
    Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.
    Kersten S
    Curr Opin Lipidol; 2019 Jun; 30(3):205-211. PubMed ID: 30893111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between ALDH2 rs671 polymorphism and lifestyle behaviors on coronary artery disease risk in a Chinese Han population with dyslipidemia: A guide to targeted heart health management.
    Huang L; Cai X; Lian F; Zhang L; Kong Y; Cao C; Ma H; Shao Y; Wu Y; Zhang B; Xu L; Yang L
    Environ Health Prev Med; 2018 Jun; 23(1):29. PubMed ID: 29960587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Vulnerable Plaque Features With Statin Therapy in Diabetic Patients With Coronary Artery Disease: Frequency-Domain Optical Coherence Tomography Analysis.
    Takata K; Kataoka Y; Andrews J; Puri R; Hammadah M; Duggal B; Kapadia SR; Tuzcu EM; Nissen SE; Nicholls SJ
    JACC Cardiovasc Imaging; 2018 Nov; 11(11):1721-1723. PubMed ID: 29680344
    [No Abstract]   [Full Text] [Related]  

  • 55. Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.
    Elam MB; Ginsberg HN; Lovato LC; Corson M; Largay J; Leiter LA; Lopez C; O'Connor PJ; Sweeney ME; Weiss D; Friedewald WT; Buse JB; Gerstein HC; Probstfield J; Grimm R; Ismail-Beigi F; Goff DC; Fleg JL; Rosenberg Y; Byington RP;
    JAMA Cardiol; 2017 Apr; 2(4):370-380. PubMed ID: 28030716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
    Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
    Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Contribution of GWAS Loci in Familial Dyslipidemias.
    Ripatti P; Rämö JT; Söderlund S; Surakka I; Matikainen N; Pirinen M; Pajukanta P; Sarin AP; Service SK; Laurila PP; Ehnholm C; Salomaa V; Wilson RK; Palotie A; Freimer NB; Taskinen MR; Ripatti S
    PLoS Genet; 2016 May; 12(5):e1006078. PubMed ID: 27227539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner.
    Liu J; Yang K; Xiao W; Le Y; Lang S; Zhang J; Wei R; Yang J; Hong T
    Peptides; 2018 Aug; 106():83-90. PubMed ID: 30003931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adiponectin gene variants and the risk of coronary artery disease in patients with type 2 diabetes.
    Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; Hussain T
    Mol Biol Rep; 2011 Aug; 38(6):3703-8. PubMed ID: 21400095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of common variants of ABCB1 and CYP7A1 genes in serum lipid levels and lipid-lowering efficacy of statin treatment: a meta-analysis.
    Li Q; Hong J; Wu J; Huang ZX; Li QJ; Yin RX; Lin QZ; Wang F
    J Clin Lipidol; 2014; 8(6):618-629. PubMed ID: 25499945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.